Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Intuitive Surgical, Inc.    ISRG

Delayed Quote. Delayed  - 09/30 10:14:59 pm
724.83 USD   +0.67%
09/30 INTUITIVE SURGI : and Fosun Pharma Establish Joint Venture to Resear..
09/29 Intuitive Surgical and Fosun Pharma Establish Joint Venture to Re..
09/25 INTUITIVE SURGI : Shares of Intuitive Surgical Sees Large Inflow of ..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Intuitive Surgical, Inc. : Fourth Quarter 2012 Earnings Conference Call

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/12/2012 | 12:45am CEST

Intuitive Surgical, Inc. (NASDAQ:ISRG), the leader in operative surgical robotics, will hold its quarterly conference call to discuss Fourth Quarter 2012 results Tuesday, January 22nd, at 4:30 p.m. Eastern Time.

This call is being webcast by Thomson Reuters and can be accessed at Intuitive Surgical's web site at www.intuitivesurgical.com.

Dial-in Numbers: (800) 230-1092 or (612) 288-0337. No passcode required.

The webcast is also being distributed over Thomson Reuters' Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through Thomson Reuters' individual investor center at www.earnings.com or by visiting any of the investor sites in Thomson Reuters' Individual Investor Network. Institutional investors can access the call via Thomson Reuters' password-protected event management site, StreetEvents (www.streetevents.com).

Intuitive Surgical, Inc.
Calvin Darling, 408-523-2161


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INTUITIVE SURGICAL, INC.
09/30 INTUITIVE SURGICAL : and Fosun Pharma Establish Joint Venture to Research, Devel..
09/29 Intuitive Surgical and Fosun Pharma Establish Joint Venture to Research, Deve..
09/25 INTUITIVE SURGICAL : Shares of Intuitive Surgical Sees Large Inflow of Net Money..
09/13 INTUITIVE SURGICAL : My Top Bet on the Robotic Surgery Revolution
09/10 INTUITIVE SURGICAL : Reports New Employee Option Grants for September 2016
09/09 Intuitive Surgical Reports New Employee Option Grants for September 2016
09/02 SUNNYVALE : Commission reviews two projects that plan to work together
08/19 INTUITIVE SURGICAL : Reports New Employee Option Grants for August 2016
08/17 Intuitive Surgical Reports New Employee Option Grants for August 2016
08/17 INTUITIVE SURGICAL : New Study Shows Robotic-Assisted Surgery Benefits For Ventr..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
09/27DJBOSTON SCIENTIFIC : to Buy EndoChoice
09/01DJPHILIPS : Appoints IBM Executive Sophie Bechu as Operations Head
08/17DJAGILENT TECHNOLOGIES : Tech Tapers Annual Outlook Amid Slowing Life Sciences Sal..
08/15DJFisher & Paykel Files Patent Infringement Claim Against ResMed
08/02DJCERNER : Edges Annual Revenue Guidance Lower
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
09/20 INTUITIVE SURGICAL : Future Bright, But Shares Overvalued
09/13 Steps To Survive The Rate Hike - Cramer's Mad Money (9/12/16)
09/02 Healthcare ratings roundup - new coverage
08/21 13 Buys And 7 Sells From The Wide-Moat Universe
07/26 Einhorn a buyer of Chemours; American Capital Agency among sales
Advertisement
Financials ($)
Sales 2016 2 647 M
EBIT 2016 1 041 M
Net income 2016 663 M
Finance 2016 1 447 M
Yield 2016 -
P/E ratio 2016 40,98
P/E ratio 2017 35,54
EV / Sales 2016 9,92x
EV / Sales 2017 8,92x
Capitalization 27 715 M
More Financials
Chart INTUITIVE SURGICAL, INC.
Duration : Period :
Intuitive Surgical, Inc. Technical Analysis Chart | ISRG | US46120E6023 | 4-Traders
Full-screen chart
Technical analysis trends INTUITIVE SURGICA...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 742 $
Spread / Average Target 3,0%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Gary S. Guthart President, Chief Executive Officer & Director
Lonnie M. Smith Chairman
Marshall L. Mohr Chief Financial Officer & Senior Vice President
Myriam J. Curet Chief Medical Officer & Senior Vice President
Alan J. Levy Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
INTUITIVE SURGICAL, IN..31.83%27 715
THERMO FISHER SCIENTIF..10.02%61 529
BOSTON SCIENTIFIC CORP..26.36%31 705
PHILIPS11.84%28 018
ILLUMINA, INC.-8.02%25 884
EDWARDS LIFESCIENCES C..51.00%25 388
More Results